Jens Neumann

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Metastatic Colorectal Cancer

Ejection Fraction

Top Venues

Virchows Archiv : an international journal of pathology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Matjaz Rokavec, Elif Özcan, Jens Neumann, Heiko Hermeking
Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer. Cancer research communications 3 (8) (2023)
Leon P Loevenich, Markus Tschurtschenthaler, Matjaz Rokavec, Miguel G Silva, Moritz Jesinghaus, Thomas Kirchner, Frederick Klauschen, Dieter Saur, Jens Neumann, Heiko Hermeking, Peter Jung
SMAD4 loss induces c-MYC-mediated NLE1 upregulation to support protein biosynthesis, colorectal cancer growth and metastasis. Cancer research (2022)
Can Lu, Josefine Schardey, Ulrich Wirth, Viktor von Ehrlich-Treuenstätt, Jens Neumann, Clemens Gießen-Jung, Jens Werner, Alexandr V Bazhin, Florian Kühn
Analysis of Circulating Immune Subsets in Primary Colorectal Cancer. Cancers 14 (24) (2022)
Can Lu, Josefine Schardey, Ulrich Wirth, Viktor von Ehrlich-Treuenstätt, Jens Neumann, Clemens Gießen-Jung, Jens Werner, Alexandr V Bazhin, Florian Kühn
Analysis of Circulating Immune Subsets in Primary Colorectal Cancer. Cancers 14 (24) (2022)
M Michl, F Taverna, J Kumbrink, T S Schiergens, V Heinemann, J Engel, T Kirchner, Jens Neumann
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer. Virchows Archiv : an international journal of pathology 478 (4) (2020)
Helena Link, Martin Angele, Miriam Schüller, Petra Ganschow, Lena Machetanz, Markus Guba, Jens Werner, Thomas Kirchner, Jens Neumann
Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer. BMC cancer 18 (1) (2018)
Jens Neumann, Volker Heinemann, Jutta Engel, Thomas Kirchner, Sebastian Stintzing
The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer. Virchows Archiv : an international journal of pathology 473 (2) (2018)